Form D · Other Technology

ImmuNovus, Inc.

Denton, NE · CIK 0002144100

Offering snapshot reported Jul 29, 2026 · SEC filing

Reported sold
$1M
Offering amount: $5M
Investors reported
2
Form D · investor count
Minimum accepted
$10
Reported outside-investor minimum
First sale
Jul 16, 2026
As reported in this filing

Fundraising history

Reported sold
Reported amount sold by Form D filing date$0$500K$1MJul 29, 2026: $750,000.00Jul 29, 2026Jul 29, 2026: $1,000,000.00Jul 29, 2026

Dates are filing dates, not cash receipt dates. Decreases are reported revisions, not evidence of withdrawals. Separate offering histories are not added together.

What changed?

Latest filing versus its linked predecessor, where available.

  • Reported sold$750,000 → $1,000,000

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Jul 29, 2026Initial$750,000No comparison2SEC filing
Jul 29, 2026Amendment$1,000,000$250,000vs Jul 29, 20262SEC filing

Offering details

Securities
Other
Exemptions
06b
Duration over one year
No
Business combination
No
Sales commissions
$0
Finders' fees
$0
Form D file number
021-592507
Simple Agreement for Future Equity (SAFE)

Source: Form D, filed Jul 29, 2026. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Tomas Helikar Executive

Issuer details

Industry: Other Technology (See others in industry)

Address:
5835 Bronco Hills Ct
Denton, NE, 68339